These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 21140061)

  • 1. [The metabolic syndrome: from an aggravating condition to a pathogenic risk factor for chronic diseases].
    Von Bernhardi R; Zanlungo S; Arrese M; Arteaga A; Rigotti A
    Rev Med Chil; 2010 Aug; 138(8):1012-9. PubMed ID: 21140061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin resistance, the insulin resistance syndrome, and cardiovascular disease.
    Reaven GM
    Panminerva Med; 2005 Dec; 47(4):201-10. PubMed ID: 16489319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The metabolic syndrome and chronic kidney disease.
    Peralta CA; Kurella M; Lo JC; Chertow GM
    Curr Opin Nephrol Hypertens; 2006 Jul; 15(4):361-5. PubMed ID: 16775449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple cardiometabolic risk factors in the Southern Cone of Latin America: a population-based study in Argentina, Chile, and Uruguay.
    Rubinstein AL; Irazola VE; Calandrelli M; Elorriaga N; Gutierrez L; Lanas F; Manfredi JA; Mores N; Olivera H; Poggio R; Ponzo J; Seron P; Chen CS; Bazzano LA; He J
    Int J Cardiol; 2015 Mar; 183():82-8. PubMed ID: 25662056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How to best define the metabolic syndrome.
    Magliano DJ; Shaw JE; Zimmet PZ
    Ann Med; 2006; 38(1):34-41. PubMed ID: 16448987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psoriasis and cardiovascular disorders.
    Frieder J; Ryan C
    G Ital Dermatol Venereol; 2016 Dec; 151(6):678-693. PubMed ID: 27627099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psoriasis comorbidities.
    Gottlieb AB; Chao C; Dann F
    J Dermatolog Treat; 2008; 19(1):5-21. PubMed ID: 18273720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of metabolic risk factors and development of cardiovascular disease and diabetes.
    Haffner SM
    Obesity (Silver Spring); 2006 Jun; 14 Suppl 3():121S-127S. PubMed ID: 16931493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic syndrome and chronic kidney disease.
    Ching-Ha Kwan B; Beddhu S
    Minerva Urol Nefrol; 2006 Mar; 58(1):1-12. PubMed ID: 16760879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The metabolic syndrome and its cardiovascular manifestations.
    Sánchez-Torres RJ; Delgado-Osorio H
    Bol Asoc Med P R; 2005; 97(4):271-80. PubMed ID: 16599068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of metabolic syndrome and cardiovascular disease in a hypertriglyceridemic population.
    Ascaso JF; Millán J; Mateo-Gallego R; Ruiz A; Suarez-Tembra M; Borrallo RM; Zambon D; Gonzalez-Santos P; Peres-de-Juan M; Ros E;
    Eur J Intern Med; 2011 Apr; 22(2):177-81. PubMed ID: 21402249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of metabolic syndrome and obstructive sleep apnea.
    Parish JM; Adam T; Facchiano L
    J Clin Sleep Med; 2007 Aug; 3(5):467-72. PubMed ID: 17803009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular morbidity and mortality of the metabolic syndrome.
    Obunai K; Jani S; Dangas GD
    Med Clin North Am; 2007 Nov; 91(6):1169-84, x. PubMed ID: 17964915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The metabolic syndrome and cardiovascular disease.
    Bonora E
    Ann Med; 2006; 38(1):64-80. PubMed ID: 16448990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical implications of the metabolic syndrome.
    Ceska R
    Diab Vasc Dis Res; 2007 Sep; 4 Suppl 3():S2-4. PubMed ID: 17935057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Metabolic syndrome and cardiovascular risk in law machinery staffers].
    Shogenova AB; El'garov AA; Murtazov AM; Shogenov AG
    Med Tr Prom Ekol; 2010; (11):7-12. PubMed ID: 21381302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of diagnosing and treating the metabolic syndrome in reducing cardiovascular risk.
    Smith SR
    Obesity (Silver Spring); 2006 Jun; 14 Suppl 3():128S-134S. PubMed ID: 16931494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic syndrome and cardiovascular risk factors in the menopausal transition.
    Siseles N; Berg G
    Gynecol Endocrinol; 2010 Jan; 26(1):1-3. PubMed ID: 19598036
    [No Abstract]   [Full Text] [Related]  

  • 19. Relationship between the metabolic syndrome and the development of hypertension in the Hong Kong Cardiovascular Risk Factor Prevalence Study-2 (CRISPS2).
    Cheung BM; Wat NM; Man YB; Tam S; Cheng CH; Leung GM; Woo J; Janus ED; Lau CP; Lam TH; Lam KS
    Am J Hypertens; 2008 Jan; 21(1):17-22. PubMed ID: 18091739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Insulin resistance, metabolic syndrome and cardiovascular diseases].
    Zeman M; Zák A; Vecka M; Tvrzická E
    Cas Lek Cesk; 2005; 144 Suppl 1():19-20, 22-6. PubMed ID: 15981981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.